Research Use Only. KIRhub outputs are computational research artifacts. They are not validated for clinical decision-making, diagnosis, or treatment.
KIRhub 2.0· v2
Ependymoma Hub
V1V2
Sign in
← Cases

Idelalisib

f3f10ff3-a677-5498-82b6-114b75e284b3 · FDA Approved · targets PI3K

Idelalisib

MeasuredReference

Idelalisib has no high-confidence primary targets in the catalog. Strongest hallmark effect: proliferation.

Primary targets

No high-confidence primary targets.

Top hallmarks

  • proliferation356
  • evading apoptosis355
  • tumor promoting inflammation320

Top pathways disrupted

  • pi3k akt mtor signaling706
  • apical junction647
  • apoptosis642

Resistance landscape — Idelalisib

MeasuredReference

No variant annotations found on Idelalisib's top targets.

No variant annotations on Idelalisib's top targets.
Open in new tab